2
Cross-border directions
Europe to China and China to overseas markets.
Europe-China medical device commercialization
Haoyi Advisory connects European and Chinese medical device and healthcare companies through market entry, partner mapping, and commercialization execution that starts with verifiable information.
7
Strategic China landing regions
Boao, Wuhan, Taizhou, Tongxiang, Shanghai, Shenzhen, and Changchun.
6
Medical device sectors
Coverage across six broad medical-device and healthcare technology groups.
3
Commercialization capabilities
Strategy, partner development, and commercial execution.
How we work
The operating model is intentionally simple: evidence first, pathway second, execution third.
01
Evidence
AI-assisted research and human review organize company materials, policy documents, regulatory evidence, and remaining information gaps.
02
Pathway
Market fit, regulatory logic, clinical relevance, and partner readiness are assessed together before commercial outreach.
03
Execution
Target mapping, outreach preparation, opportunity qualification, meeting support, and structured follow-up are kept tied to clear next steps.
Start with a focused conversation
Haoyi Advisory is best suited for companies and partners seeking practical, evidence-aware commercialization routes across Europe and China.